FGF5 and nasopharyngeal carcinoma: Additionally, the role of CAFs as a potential source of FGF5 in the tumor microenvironment warrants further investigation, as targeting CAF-derived FGF5 may provide a novel strategy to overcome treatment resistance in NPC.